Haemonetics Corp (NYSE:HAE)

92.82
Delayed Data
As of Jun 19
 0.00 / 0.00%
Today’s Change
38.47
Today|||52-Week Range
96.84
+59.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues910.4M910.5M886.1M903.9M
 
 
 
 
 
Cost of Goods Sold389.9M404.2M401.4M397.9M
 
 
 
 
 
Depreciation And Amortization86.1M89.9M89.7M89.2M
 
 
 
 
 
 
Operating ExpensesGross Income434.4M416.4M395.0M416.8M
 
 
 
 
 
General Expenses321.7M319.9M299.7M310.0M
 
 
 
 
 
Research And Development54.2M45.0M37.6M39.2M
 
 
 
 
 
Total Operating Expenses797.6M814.0M790.9M797.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income112.8M96.5M95.3M106.8M
 
 
 
 
 
Extraordinary Credit2.9M4.7M857.0K--
 
 
 
 
Extraordinary Charge-72.2M-143.6M-109.4M-49.7M
 
 
 
 
 
Interest Expense On Debt8.7M8.5M9.0M4.5M
 
 
 
 
 
Other Expenses-3.8M-2.6M-5.2M6.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income31.2M-53.4M-27.5M59.6M
 
 
 
 
 
Income Taxes-14.3M-2.2M-1.2M-14.1M
 
 
 
 
 
Net Income16.9M-55.6M-26.3M45.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.5M50.9M51.5M52.8M
 
 
 
 
 
Shares To Calculate EPS Diluted52.1M50.9M51.5M53.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.32-$1.09-$0.51$0.85
 
 
 
 
 
EPS Diluted$0.32-$1.09-$0.51$0.85